Xenetic Biosciences (XBIO) Stock: Buy, Sell, or Hold?
XBIO - Xenetic Biosciences, Inc.
$2.24
0.00 (0.00%)
▲
5d:
-6.28%
30d:
-47.29%
90d:
-21.4%
HOLD
LOW Confidence
Analysis Updated: Oct 2, 2026 12:00 AM ET
Earnings: Nov 11, 2026
Get Alerted When XBIO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: XBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: XBIO shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: XBIO is currently trading at $2.24, which is considered oversold relative to its 30-day fair value range of $2.48 to $4.27.
Technical Outlook: Technically, XBIO is showing sideways momentum. Immediate support is located at $2.11, while resistance sits at $3.10.
Market Sentiment: XBIO scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $40.00 (+1685.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XBIO is showing sideways momentum. Immediate support is located at $2.11, while resistance sits at $3.10.
Market Sentiment: XBIO scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $40.00 (+1685.7%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$2.48 -
$4.27
Company Quality Score
58/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
89.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: Trading 1685.7% below Wall St target ($40.00)
- CAUTION: Bottoming setup, but lagging the sector by 66% over 20 days — wait for relative strength
- CAUTION: 5-day price weakness (-6.3%) - monitor closely
Trading Range Analysis
30-Day Trading Range
$2.48 -
$4.27
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$2.11
Resistance Level
$3.10
Current Trend
Sideways
Technical data as of
Oct 2, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-6.59
Wall Street Target
$40.00
(+1685.7%)
Revenue Growth (YoY)
12.0%
Profit Margin
-75.9%
Share & Embed Analysis
Last updated: October 03, 2026 1:15 PM ET
Data refreshes hourly during market hours. Next update: 2:15 PM
Data refreshes hourly during market hours. Next update: 2:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XBIO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 54 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$199 | 49 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 63 BUY |
|
CRNX
Crinetics Pharmaceutical… |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
|
BHVN
Biohaven Ltd. |
STRONG BUY
16 analysts |
$21 | 50 HOLD |
